Figure 7.
The blood pressure and heart rate responses observed during the continuous intrathecal infusion of ziconotide. From 0 to 48 hr, ziconotide was infused at 1 µg/hr. From 48 to 96 hr, ziconotide was delivered at the rate of 5 µg/hr. Results presented represent the mean and SEM of data from 5 dogs.